Skip to main content
. Author manuscript; available in PMC: 2007 Jun 1.
Published in final edited form as: Am J Med. 2006 Jun;119(6):494–502. doi: 10.1016/j.amjmed.2005.11.011

Table 4.

Incidence of colorectal cancer after randomization to study aspirin or self-selected initiation of any regular nonsteroidal anti-inflammatory drug use (including study and non-study aspirin) in the Physician’s Health Study

Age-adjusted Fully-adjusted*
Duration of regular aspirin or NSAID use after randomization or self-selected initiation Person-years Events IR per 100,000 p-y RR 95% CI RR 95% CI
Never 88,616 108 122 1.0 reference 1.0 reference
 1 – 5 years 97,286 124 127 1.0 0.7 – 1.3 0.9 0.7 – 1.2
 6 – 10 years 103,008 157 152 1.0 0.7 – 1.3 0.9 0.7 – 1.3
 More than 10 years 76,915 106 138 0.9 0.6 – 1.2 0.8 0.6 – 1.2
*

Rate ratios and their 95% confidence intervals from time-varying Cox proportional hazards model controlling for all variables presented in table 2: age (continuous, linear and squared), body mass index (continuous), vigorous exercise (5 categories), smoking (never, former, current), alcohol consumption (6 categories), multivitamin use, consumption of fruits and vegetables (servings per day, continuous), as well as history of hypertension, diabetes, coronary artery disease (myocardial infarction, coronary artery bypass grafting, or percutaneous transluminal coronary angioplasty), angina, headache, migraine, peptic ulcer, gastrointestinal bleeding, and gastritis; variables are updated during follow-up whenever possible